Forma Therapeutics Holdings (FMTX) Misses Q4 EPS by 10c

Forma Therapeutics Holdings (NASDAQ: FMTX) reported Q4 EPS of ($1.06), $0.10 worse than the analyst estimate of ($0.96). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Forma Therapeutics Holdings (FMTX) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BofA maintains underperform ratings on six BDC stocks
• Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions